Pathogenesis of bone and cartilage destruction in rheumatoid arthritis.
about
Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone lossSignalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1Hypoxia-Inducible Factor (HIF) as a Target for Novel Therapies in Rheumatoid ArthritisInteractions of the protein-tyrosine phosphatase-α with the focal adhesion targeting domain of focal adhesion kinase are involved in interleukin-1 signaling in fibroblasts.In vitro model for the analysis of synovial fibroblast-mediated degradation of intact cartilage.Development of cell-based high-throughput assays for the identification of inhibitors of receptor activator of nuclear factor-kappa B signaling.Central IL-1 receptor signaling regulates bone growth and massInterleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications.Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis.Receptor activator of NF-{kappa}B (RANK) cytoplasmic IVVY535-538 motif plays an essential role in tumor necrosis factor-{alpha} (TNF)-mediated osteoclastogenesis.Serum sclerostin in high-activity adult patients with juvenile idiopathic arthritis.Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical TrialsCirculating protein fragments of cartilage and connective tissue degradation are diagnostic and prognostic markers of rheumatoid arthritis and ankylosing spondylitis.Secondary osteoporosis in patients with juvenile idiopathic arthritis.Osteoblasts from osteoarthritis patients show enhanced susceptibility to Ross River virus infection associated with delayed type I interferon responses.Effects of antibody to receptor activator of nuclear factor κ-B ligand on inflammation and cartilage degradation in collagen antibody-induced arthritis in mice.A broad analysis of IL1 polymorphism and rheumatoid arthritis.Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis.Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy.The association between lean mass and bone mineral content in the high disease activity group of adult patients with juvenile idiopathic arthritis.Radiographic estimation in seropositive and seronegative rheumatoid arthritisChanges in cotherapies after initiation of disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritisTNF-induced structural joint damage is mediated by IL-1.Is monocyte chemotactic protein 1 elevated in aseptic loosening of TKA? A pilot study.Paget disease of bone.Green Tea Epigallocatechin-3-Gallate Suppresses Autoimmune Arthritis Through Indoleamine-2,3-Dioxygenase Expressing Dendritic Cells and the Nuclear Factor, Erythroid 2-Like 2 Antioxidant Pathway.RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritisProteinases in the joint: clinical relevance of proteinases in joint destructionCD146+ mesenchymal stem cells display greater therapeutic potential than CD146- cells for treating collagen-induced arthritis in mice.Metacarpal Index Estimated by Digital X-ray Radiogrammetry as a Tool for Differentiating Rheumatoid Arthritis Related Periarticular Osteopenia.Ubiquitin ligase Smurf1 mediates tumor necrosis factor-induced systemic bone loss by promoting proteasomal degradation of bone morphogenetic signaling proteins.Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regenerationDifferential diagnosis of systemic lupus erythematosus and rheumatoid arthritis with complements C3 and C4 and C-reactive protein.Antibodies to cyclic citrullinated protein and erythrocyte sedimentation rate predict hand bone loss in patients with rheumatoid arthritis of short duration: a longitudinal study.Breaking old paradigms: Th17 cells in autoimmune arthritis.Chemical and Biochemical Basis of Cell-Bone Matrix Interaction in Health and Disease.Endothelial protein C receptor-associated invasiveness of rheumatoid synovial fibroblasts is likely driven by group V secretory phospholipase A2.Scientific basis of botanical medicine as alternative remedies for rheumatoid arthritis.Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study.N-feruloylserotonin in preventive combination therapy with methotrexate reduced inflammation in adjuvant arthritis.
P2860
Q24701798-4A892695-A650-4198-BC2B-D6B2401387A3Q24816719-2041C34D-9D6A-4140-BE74-74714F58CA6AQ26738338-78D110AA-82AE-4C65-B40C-F29FAB9B7C44Q30384601-AD5822CA-02A8-46B8-8255-EAA191257AB6Q33410403-4309C806-9AFA-44F7-AE8C-125BC999C969Q33738074-60574C42-0E20-4A94-93B0-103FB3FF2B0FQ33943828-64AA2D13-89FE-490A-9B83-E7CB9DD5544EQ34047753-6B90EA66-7797-42F9-8F3D-6B5CC7A914F0Q34090842-6B313096-B278-4B26-9E3F-25AC0DBE8A7FQ34333628-5CDF4378-60C3-4FB2-A712-57DD11658D99Q34537434-5B58C941-35AE-4236-8652-633B850515D8Q34537663-F13E9391-5F4D-4B00-9B08-04D370699BFFQ34568353-CB39820A-798A-4D9E-8525-400E4362AE12Q34595120-77E8B179-4CBA-41D3-BD83-64CA446DC4E8Q34611938-A1D02A84-6472-4B3D-B8E4-C1F2494617B9Q34746798-2ED6B50D-0FC5-43D9-8A66-6B6824B2D84FQ34788695-CD8AE408-2B34-4FB9-BBEB-515F99542DBFQ34896346-B65ECB86-F4DB-40CB-9738-59F70F9BE286Q35055978-3DFF695E-643E-40AB-9861-B175F2C930CCQ35099938-BF3BF7A5-84DB-483F-BCB1-21E7CC20CEB9Q35184666-A54AE48C-F77E-4E09-8AE7-C347DF54BC17Q35581451-FA5679AF-7C5D-4566-AF2C-45455EE1FD49Q35880188-A06A70F2-549B-43B9-91F6-A317DB91FA03Q36013306-C668D61D-D72B-45C9-8F03-A7E738E73847Q36029217-B7170141-CBD2-4EDE-9AAF-D2EBA319F8D9Q36062141-41DBF87D-E3EB-4159-87A3-74D0D2AAFFE2Q36246148-6B7F38FB-B6D6-4AFB-A32C-5774843EAA2CQ36401848-1E3ED58B-338D-4EC9-85F8-C3A25BB86DF7Q36543020-CDCF6ECE-7892-4F04-AA03-C981ED3D5385Q36735209-A35F1B5D-0870-4C72-8443-544AA7E990DDQ36838785-32BEFA3C-020C-4E7C-B8D2-7FD594A30C1EQ37207085-56F36EF3-3D24-4B5A-A4CF-7B33DB12C2E7Q37289115-A5985D20-CF12-4CB5-8C75-17A89BBBDA50Q37350853-4C48C7E4-4770-4C91-B921-3A549D0777E1Q37464427-B0D59186-ADB5-4267-B5F2-443A327FE05DQ37464897-F6EE756E-3AB9-42AB-B608-D9DBCDB15653Q37691187-074559B5-F24A-4F10-8E0A-E2C14719F7DFQ38018879-58EE7A45-9A8D-4538-9D31-8EFC4BA73094Q38274496-E0A7626C-AA22-45B4-9C74-6401937E6289Q39177048-62A5F47D-26CC-4C55-9E20-61CA67EBECB5
P2860
Pathogenesis of bone and cartilage destruction in rheumatoid arthritis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pathogenesis of bone and cartilage destruction in rheumatoid arthritis.
@ast
Pathogenesis of bone and cartilage destruction in rheumatoid arthritis.
@en
type
label
Pathogenesis of bone and cartilage destruction in rheumatoid arthritis.
@ast
Pathogenesis of bone and cartilage destruction in rheumatoid arthritis.
@en
prefLabel
Pathogenesis of bone and cartilage destruction in rheumatoid arthritis.
@ast
Pathogenesis of bone and cartilage destruction in rheumatoid arthritis.
@en
P356
P1433
P1476
Pathogenesis of bone and cartilage destruction in rheumatoid arthritis.
@en
P2093
Goldring SR
P304
P356
10.1093/RHEUMATOLOGY/KEG327
P478
42 Suppl 2
P577
2003-05-01T00:00:00Z